SCHEMBL6008053

SCHEMBL6008053

CS(=O)(=O)NC(CCN1CCC(Cc2ccccc2)CC1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.54
SLC6A3 Q01959 2/20 0.54
PRMT6 Q96LA8 3/20 0.53
CARM1 Q86X55 2/20 0.53
GRIN2D O15399 1/20 0.53
GRIN3B O60391 1/20 0.53
ADRA1D P25100 1/20 0.53
ADRA1A P35348 1/20 0.53
ADRA1B P35368 1/20 0.53
GRIN1 Q05586 1/20 0.53
GRIN2A Q12879 1/20 0.53
GRIN2B Q13224 1/20 0.53
GRIN2C Q14957 1/20 0.53
GRIN3A Q8TCU5 1/20 0.53
CCR3 P51677 1/20 0.51
OPRM1 P35372 1/20 0.51
CCR5 P51681 1/20 0.50
PRMT3 O60678 1/20 0.50
PRMT1 Q99873 1/20 0.50
PRMT8 Q9NR22 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448769 0.87 SLC6A2 (0.53) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6007229 0.85 KDM4E (0.56) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6008830 0.84 PRMT6 (0.63) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6007222 0.82 ALDH1A1 (0.56) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6009357 0.82 TMEM97 (0.47) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6008682 0.82 OPRM1 (0.46) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6007211 0.81 SLC6A2 (0.60) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6007244 0.81 SLC6A2 (0.56) SLC6A2SLC6A3PRMT6CARM1GRIN2D
SCHEMBL6008029 0.78 CCR3 (0.60) SLC6A2SLC6A3GRIN2DGRIN3BADRA1D
SCHEMBL6006925 0.78 LMNA (0.49) SLC6A2SLC6A3GRIN2AGRIN2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US claimed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US claimed
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US disclosed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SIGMAR1, TAAR1, OPRL1 SLC6A2 20/4885SLC6A3 10/4885PRMT6 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.